biospecimen_aliquot__bcr_aliquot_barcode	tcga-bh-a0dz-01a-11w-a019-09
biospecimen_aliquot__bcr_aliquot_uuid	d6418b7f-96b4-424a-8737-d382ece37afe
biospecimen_aliquot__bcr_patient_uuid	478eb8aa-50b8-4ce5-98e4-d518ede4b174
biospecimen_aliquot__bcr_sample_barcode	tcga-bh-a0dz-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099034636
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.50
biospecimen_aliquot__date_of_shipment	2010-06-29
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	11
biospecimen_aliquot__plate_id	a019
biospecimen_aliquot__plate_row	e
biospecimen_aliquot__quantity	40.00
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	80.00
biospecimen_analyte__analyte_type	repli-g (qiagen) dna
biospecimen_analyte__analyte_type_id	w
biospecimen_analyte__bcr_analyte_barcode	tcga-bh-a0dz-01a-11w
biospecimen_analyte__bcr_analyte_uuid	de193015-2d67-4dfb-bc04-b682c63d016a
biospecimen_analyte__bcr_patient_uuid	478eb8aa-50b8-4ce5-98e4-d518ede4b174
biospecimen_analyte__bcr_sample_barcode	tcga-bh-a0dz-01a
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-bh-a0dz
biospecimen_diagnostic_slides__bcr_patient_uuid	478eb8aa-50b8-4ce5-98e4-d518ede4b174
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-bh-a0dz-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	138baec2-589e-4960-b94e-df48ddaa5490
biospecimen_normal_control__bcr_patient_barcode	tcga-bh-a0dz
biospecimen_normal_control__bcr_patient_uuid	478eb8aa-50b8-4ce5-98e4-d518ede4b174
biospecimen_normal_control__normal_tissue_anatomic_site	breast
biospecimen_portion__bcr_patient_uuid	478eb8aa-50b8-4ce5-98e4-d518ede4b174
biospecimen_portion__bcr_portion_barcode	tcga-bh-a0dz-01a-11
biospecimen_portion__bcr_portion_uuid	04e4a6a8-c5ee-435c-8852-dadb485071bc
biospecimen_portion__bcr_sample_barcode	tcga-bh-a0dz-01a
biospecimen_portion__date_of_creation	2010-06-09
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-bh-a0dz-01a-11w
biospecimen_protocol__bcr_patient_uuid	478eb8aa-50b8-4ce5-98e4-d518ede4b174
biospecimen_protocol__bcr_sample_barcode	tcga-bh-a0dz-01a
biospecimen_sample__bcr_patient_uuid	478eb8aa-50b8-4ce5-98e4-d518ede4b174
biospecimen_sample__bcr_sample_barcode	tcga-bh-a0dz-01a
biospecimen_sample__bcr_sample_uuid	6093f268-1c3f-4fec-bde7-fc3721ecaf8e
biospecimen_sample__days_to_collection	308
biospecimen_sample__initial_weight	170
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-bh-a0dz.16de55ce-076e-43d3-84bd-332a79b95efd.pdf
biospecimen_sample__pathology_report_uuid	16de55ce-076e-43d3-84bd-332a79b95efd
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_slide__bcr_patient_uuid	478eb8aa-50b8-4ce5-98e4-d518ede4b174
biospecimen_slide__bcr_sample_barcode	tcga-bh-a0dz-01a
biospecimen_slide__bcr_slide_barcode	tcga-bh-a0dz-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	482fc6f8-5c8b-494e-a821-628daa343534
biospecimen_slide__image_file_name	tcga-bh-a0dz-01a-01-tsa.482fc6f8-5c8b-494e-a821-628daa343534.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	1
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	1
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	29
biospecimen_slide__percent_stromal_cells	0
biospecimen_slide__percent_tumor_cells	70
biospecimen_slide__percent_tumor_nuclei	92
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-bh-a0dz
biospecimen_tumor_sample__bcr_patient_uuid	478eb8aa-50b8-4ce5-98e4-d518ede4b174
clinical_drug__bcr_drug_barcode	tcga-bh-a0dz-d4577
clinical_drug__bcr_drug_uuid	ac6c5d22-298b-4e01-a4bb-024810bf148a
clinical_drug__bcr_patient_barcode	tcga-bh-a0dz
clinical_drug__bcr_patient_uuid	478eb8aa-50b8-4ce5-98e4-d518ede4b174
clinical_drug__form_completion_date	2010-11-17
clinical_drug__pharmaceutical_therapy_drug_name	tamoxifen
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	234
clinical_drug__prescribed_dose	20
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	po
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-bh-a0dz-f4588
clinical_follow_up__bcr_followup_uuid	f7218f8f-0d41-4b86-b276-c020ca69412e
clinical_follow_up__bcr_patient_barcode	tcga-bh-a0dz
clinical_follow_up__bcr_patient_uuid	478eb8aa-50b8-4ce5-98e4-d518ede4b174
clinical_follow_up__form_completion_date	2010-11-16
clinical_follow_up__last_contact_days_to	495
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_nte__bcr_patient_barcode	tcga-bh-a0dz
clinical_nte__bcr_patient_uuid	478eb8aa-50b8-4ce5-98e4-d518ede4b174
clinical_patient__age_at_diagnosis	43
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1a
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	right upper inner quadrant|right upper outer quadrant|right lower inner quadrant|right lower outer quadrant|right
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-bh-a0dz
clinical_patient__bcr_patient_uuid	478eb8aa-50b8-4ce5-98e4-d518ede4b174
clinical_patient__birth_days_to	-15980
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_ihc_score	2+
clinical_patient__er_positivity_method	h-score 140
clinical_patient__er_positivity_scale_other	h-score
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	50-59%
clinical_patient__form_completion_date	2010-11-9
clinical_patient__gender	female
clinical_patient__her2_ihc_percent_positive	30-39%
clinical_patient__her2_ihc_score	3+
clinical_patient__her2_status_by_ihc	positive
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2009
clinical_patient__last_contact_days_to	495
clinical_patient__lymph_nodes_examined_count	5
clinical_patient__lymph_nodes_examined_he_count	1
clinical_patient__margin_status	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a0dz
clinical_patient__pr_positivity_define_method	h-score 15
clinical_patient__pr_positivity_ihc_intensity_score	2+
clinical_patient__pr_positivity_scale_other	h-score
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	<10%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	simple mastectomy
clinical_patient__tissue_source_site	bh
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0DZ-01A-11W-A019-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0DZ-01A-11W-A019-09.bed.meta
manually_curated__id	tcga-bh-a0dz-01a-11w-a019-09
manually_curated__md5sum	f8dc3835a0ebd001975f7d451337ba6d
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	d6418b7f-96b4-424a-8737-d382ece37afe
manually_curated__tumor_tag	brca
